Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Lands' End, City National, Covenant

Thu, 22nd Jan 2015 14:20

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s) U.S. stock index futures pointed to modest gains at the open onThursday after the European Central Bank announced expandedmeasures to stimulate the region's economy. Dow Jones industrialaverage e-mini futures were up 0.54 percent at 17,585,S&P 500 e-mini futures were up 0.64 percent at 2,039.5and Nasdaq 100 e-mini futures were up 0.55 percent at4,205.75.

** LANDS' END INC , Wednesday close $50.71, -21.91pct premarket

The apparel retailer forecast lower revenue from merchandisesales and services in the fourth quarter. "We were disappointedby the performance of our cold weather assortment, especiallyduring the peak holiday period," Chief Executive Edgar Hubersaid. International business was affected by unfavorable changesin currency exchange rates and lower sales in Europe. Thecompany, spun off from Sears Holdings Corp last year,forecast Q4 earnings much below analysts' average estimate.

** CITY NATIONAL CORP, Wednesday close$74.57, +18.40 pct premarket

Royal Bank of Canada said it would buy theU.S. lender serving high net worth clients in a cash-and-stockdeal valued at $5.4 billion. RBC offered $47.25 in cash and0.7489 in shares for each City National share. The total offerof $93.80 per share, based on RBC's closing price of $62.16 onthe New York Stock Exchange on Wednesday, represents a premiumof nearly 26 percent to City National's last closing price.

** F5 NETWORKS INC, Wednesday close $125.95, -14.41pct premarket

The network equipment maker reported revenue that missedWall Street's estimates for the first time in eight quarters dueto "a marked decrease in the number of deals greater than $1million".

At least 8 brokerages cut price targets on the stock by asmuch as $25 to as low as $105; Median target price $133

"Comps become much more difficult in the coming quarters andthe company will have to prove that newer initiatives likesecurity can drive revenue re-acceleration and sustainabledouble-digit growth" Barclays analysts wrote in a note.

** LOGITECH INTERNATIONAL SA, Wednesday close$14.09, +8.16 pct premarket

The company increased profitability outlook for full year2015. The traders cited strong EBIT number of $76.4 mln for thethird quarter. The stock was the top riser on Stoxx 600, with a full-day's 30-day average volume alreadytraded.

** PETROBRAS , Wednesday close $7.35, +5.71 pctpremarket

** TOTAL SA , Wednesday close $51.64, +0.35 pctpremarket

** BP Plc , Wednesday close $38.82, +0.41 pctpremarket

** HALLIBURTON CO , Wednesday close $40.69, +0.27pct premarket

** SCHLUMBERGER LTD , Wednesday close $82.21, +0.57pct premarket

** SEADRILL LTD , Wednesday close $10.38, +3.37 pctpremarket

** TRANSOCEAN LTD , Wednesday close $16.06, +1.49pct premarket

** NABORS INDUSTRIES LTD , Wednesday close$10.86, +1.20 pct premarket

Brent crude rose ahead of an expected decision by EuropeanCentral Bank to start buying bonds, a move which could pushdollar to new highs and put downward pressure on commodities.Brent crude up 2 pct at $49.99 per barrel; U.S. crude up 1.5 pct at $48.49 per barrel.

** BLACKBERRY LTD, Wednesday close $9.93, +5.54 pctpremarket

Samsung Electronics Co Ltd is actively pursuinga plan to take over or buy a significant stake in the canadiancompany despite statements from both companies this weekdenying that such a plan may be in the works, Canada's FinancialPost reported. (http://bit.ly/1wpG0Ue)

** XILINX INC, Wednesday close $41.51, -7.25 pctpremarket

The programmable-chip maker's shares forecast Q3 revenue andQ4 revenue below analysts' average estimates. Results andforecast hurt by weak sales to broadcast and communicationscustomers.

At least nine brokerages cut price targets, with Robert W.Baird & Co slashing by $8.00 to $44.00

** MEDIVATION , Wednesday close $111.2, -3.39 pctpremarket

The drug developer says its prostate cancer therapy Xtandiwas not as safe as AstraZeneca Plc's treatment Casodexin a mid-stage study. 31 pct patients given Xtandi had seriousadverse reactions compared with 23.3 pct patients who were givenCasodex. Xtandi increased the time patients survived withoutprogression of the disease to 15.7 months, compared to 5.8months among Casodex patients.

** COVENANT TRANSPORTATION, Wednesday close$24.76, +9.05 pct premarket

The transportation services provider's Q4 earnings 82 centsper share came above the average analyst estimate 74 cents. Peakholiday shipping, lower fuel costs boosted profit, CEO DavidParker said.

** SANDISK CORP, Wednesday close $80.44, -6.51 pctpremarket

The memory chip maker forecast current-quarter andfull-year 2015 revenue well below Wall Street expectations,saying it would be unable to meet demand for flash memorystorage chips until mid-year due to lean inventory levels.

** KERYX BIOPHARMACEUTICALS INC, Wednesday close$12.87, -2.41 pct premarket

The drug developer's offering of 9.2 mln shares priced at$12 each, a discount of 6.8 pct to Wednesday's close. Thecompany, which had 91.9 mln shares outstanding as of Wednesday'sclose, said it would use $110 mln proceeds to fund marketing ofrecently approved chronic kidney disease treatment Auryxia.

** INTREXON CORP, Wednesday close $28.4, -1.37 pctpremarket

The synthetic biology company's offering of 3.8 millionshares priced at $27.00 each, a discount of 4.9 pct to thestock's Wednesday's closing price. Company had about 100.5 mlnshares outstanding as of Wednesday, according to Thomson Reutersdata.

** BIOMARIN PHARMACEUTICAL INC, Wednesday close$96.14, -2.86 pct premarket

The drugmaker's offering of 8.5 mln shares priced at $93.25each, a 3 pct discount to the stock's Wednesday close. THecompany had 147.4 mln shares outstanding as of Sept. 30,according to Thomson Reuters data. Says to use net proceeds tofund acquisition of Dutch drug developer Prosensa Holding NV and for general corporate purposes.

** AMERICAN EXPRESS CO, Wednesday close$87.67, -2.69 pct premarket

The world's largest credit card issuer will cut more than4,000 jobs this year, an executive said, after the credit cardcompany also reported higher quarterly expenses and provisionsfor bad loans. The planned redundancies, from a workforce ofnearly 63,000, contributed to a $313 million pre-taxrestructuring charge.

Jefferies cuts price target to $90 from $95, Barclays to $96from $100, and Bernstein to $97 from $99.

** EBAY INC, Wednesday close $53.38, +3.03 pctpremarket

The company plans to break up into three different companiesto accommodate would-be suitors, signaling a potential mergerfight after the breakup.

The company plans to spin off its payments division,PayPal, from its core marketplace division in the second half ofthe year, making two standalone publicly traded companies thatsome analysts say could be worth more than the combinedentity.

Cowen and Co raises price target to $57 from $55, RBCCapital Markets to $58 from $55 and Susquehanna Financial Groupto $59 from $52.

** VERIZON COMMUNICATIONS INC, Wednesday close$48.25, -0.41 pct premarket

THe company's quarterly revenue rose 6.8 percent due tohigher net addition of postpaid subscribers and a rise inaverage revenue per account as users added more devices toshared data plans. The company, however, reported a loss of$2.15 billion, or 54 cents per share, for the fourth quartercompared with a profit of $7.92 billion, or $1.76 per share, ayear earlier, mainly due to valuation of benefits plan andpension adjustments.

** MICROSOFT CORP, Wednesday close $45.92, +0.78pct premarket

The ageing tech pioneer surprised the tech world onWednesday with a prototype hologram visor that can bring theMinecraft video game, Skype calls and even the landscape of Marsto three-dimensional life.

** SALLIE MAE CORP, Wednesday close $9.69, -13.21pct premarket

The provider of student loans forecasted 2015 EPS of 48-50cents below analysts average estimate of 62 cents, according toThomson Reuters I/B/E/S. Net income for the fourth quarterplunged 75 pct to $14.9 million, missing analysts' averageestimate. Provision for loan losses rises 7 pct to $30 millionin Q4.

** FAMILY DOLLAR STORES INC, Wednesday close $75.55

The shareholders are expected to vote in favor of a pending$8.5 billion merger with Dollar Tree Inc despite ahigher offer from Dollar General still on the table,according to people familiar with the matter.

The vote, which is scheduled for Thursday, comes afterinfluential proxy advisory firm Institutional ShareholderServices said Dollar Tree's proposal was in the best interest ofshareholders and was more likely to close as it faces fewerantitrust hurdles than the Dollar General offer. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.